Roche Posts 7% Sales Growth in Q1

Sales at its pharmaceutical division grew 8%

Swiss pharmaceutical giant Roche said on April 16 sales had soared 7% to 11.6 billion francs (US$ 10.13 billion) in the first quarter of 2009, outstripping the global market.

Sales at its pharmaceutical division grew 8% to 9.21 billion francs, driven by its oncology, inflammation and ophthalmology portfolios.

Sales at its diagnostics division also rose 3% to 2.36 billion francs.

"Sales in both divisions continued to grow significantly faster than their respective markets. We are therefore confident that we can achieve our full-year targets, said Roche chief executive Severin Schwan.

He added that the group would update its full-year outlook when it reported its first-half results in July to include the impact of the group's buyout of U.S. biotechnology unit Genentech. Roche last month agreed to pay $46.8 billion to take full control of Genentech.

Copyright Agence France-Presse, 2009

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.